Stacchiotti, S <br/><br/>
Phase II study on lapatinib in advanced EGFR-positive chordoma.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jul 2013 
 - 1931-1936 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdt117  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Bone Neoplasms--drug therapy<br/>Chordoma--drug therapy<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>ErbB Receptors--metabolism<br/>Female<br/>Humans<br/>Lapatinib<br/>Male<br/>Middle Aged<br/>Quinazolines--administration & dosage<br/>Sacrum--pathology<br/>Skull Base--pathology<br/>Treatment Outcome